Literature DB >> 24216123

Comparison of transesophageal echocardiography versus computed tomography for detection of left atrial appendage filling defect (thrombus).

Matthew J Budoff1, Adekunle Shittu2, Yalcin Hacioglu2, Eli Gang3, Dong Li2, Harpreet Bhatia3, Juan Alvergue3, Ronald P Karlsberg3.   

Abstract

Patients with atrial fibrillation, who are referred for radiofrequency pulmonary vein antral isolation, frequently undergo transesophageal echocardiography (TEE) to detect and/or exclude left atrial or left atrial appendage (LAA) thrombus and cardiac computed tomographic angiography (CCTA) to define and/or evaluate left atrial and pulmonary venous anatomy. Previous studies have reported CCTA to have high sensitivity and negative predictive value (NPV) for detecting thrombus in the LAA. Previous studies determining an optimal LAA/ascending aorta (AA) Hounsfield unit (HU) density ratio for detection of LAA thrombus have been small, with limited numbers of thrombi. We thus sought to determine both the optimal cutoff for LAA HU density and LAA/AA HU density ratio in detecting LAA thrombus compared with TEE in a multicenter population. We included 84 patients who had undergone CCTA and TEE. LAA was evaluated by 64-row CCTA qualitatively (visual filling defect) and quantitatively (measurement of LAA HU density and LAA/AA HU density ratio), using a 1-cm area of interest in the same axial plane. Results were compared with TEE visualization of thrombus or spontaneous echo contrast. Qualitative identification of thrombus in LAA by CCTA compared with TEE detection of thrombus had a sensitivity of 100%, a specificity of 77.9%, a positive predictive value (PPV) of 51.6%, an NPV of 100%, and a total accuracy of 82.1%. The optimal LAA HU density cutoff for thrombus detection was 119 with a sensitivity of 88%, a specificity of 86%, PPV 56%, and an area under the curve of 0.923 (p = 0.0004). The optimal LAA/aorta HU ratio was 0.242 with a sensitivity of 87%, a specificity of 88%, a PPV of 64%, and an area under the curve of 0.921 (p = 0.0011). There is no significant difference (p = 0.72) between both areas under the curve, and both measurements improved the specificity and PPV compared with qualitative measures. Multidetector computed tomography is an imaging technique that can exclude LAA thrombus with very high NPV. Quantitative measurement of LAA HU density (cutoff 119) or LAA/aorta HU density ratio (cutoff 0.242) improves accuracy of positively detecting LAA thrombus. This technique is especially useful when delayed scanning is not performed and LAA is found incidentally after the patient scanning is complete.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24216123     DOI: 10.1016/j.amjcard.2013.09.037

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Predicting Left Atrial Appendage Thrombus from Left Atrial Volume and Confirmation by Computed Tomography with Delayed Enhancement.

Authors:  Kazuhiro Osawa; Rine Nakanishi; Indre Ceponiene; Negin Nezarat; William J French; Matthew J Budoff
Journal:  Tex Heart Inst J       Date:  2020-04-01

2.  Sex-specific biatrial volumetric measurements obtained with use of multidetector computed tomography in subjects with and without coronary artery disease.

Authors:  Matthew J Budoff; Sandeep R Pagali; Yasmin S Hamirani; Andy Chen; Gordon Cheu; Yanlin Gao; Dong Li; SongShou Mao
Journal:  Tex Heart Inst J       Date:  2014-06-01

3.  Accuracy of cardiac CT in evaluating severity of left atrial appendage spontaneous echo contrast: comparison with transesophageal echocardiography.

Authors:  Chun-Li He; Zhao-Qian Wang; Chong-Fu Jia; Tao Cong; Liang Zhang; Zhi-Qiang Yang; Xi-Xia Sun; Si-Yao Sun
Journal:  Int J Cardiovasc Imaging       Date:  2018-02-19       Impact factor: 2.357

Review 4.  Computed tomography measurement for left atrial appendage closure.

Authors:  Masahiko Asami
Journal:  Cardiovasc Interv Ther       Date:  2022-03-20

5.  Transoesophageal echocardiography prior to catheter ablation could be avoided in atrial fibrillation patients with a low risk of stroke and without filling defects in the late-phase MDCT scan: A retrospective analysis of 783 patients.

Authors:  Zhengqin Zhai; Min Tang; Shu Zhang; Pihua Fang; Yuhe Jia; Tianjie Feng; Jiande Wang
Journal:  Eur Radiol       Date:  2017-12-07       Impact factor: 5.315

6.  Diagnosis of left atrial appendage thrombus in patients with atrial fibrillation: delayed contrast-enhanced cardiac CT.

Authors:  Pietro Spagnolo; Manuela Giglio; Daniela Di Marco; Paola M Cannaò; Eustachio Agricola; Paolo E Della Bella; Caterina B Monti; Francesco Sardanelli
Journal:  Eur Radiol       Date:  2020-09-04       Impact factor: 5.315

7.  Prevalence of intracardiac thrombi on cardiac computed tomography angiography: Outcome and impact on consequent management.

Authors:  Narumol Chaosuwannakit; Pattarapong Makarawate
Journal:  Eur J Radiol Open       Date:  2021-02-16

8.  Feasibility of the Big 5-Jena eCS Protocol : First Experience Implementing a New Extended CT Protocol in the Initial Diagnostics of Ischemic Stroke.

Authors:  Moisés F Molina-Fuentes; Rotraud Neumann; Wilhelm Behringer; Marcus Franz; P Christian Schulze; Otto W Witte; Albrecht Günther; Carsten Klingner; Lukas Lehmkuhl; Beatrice Steiniger; Ulf Teichgräber; J E Rod; Thomas E Mayer
Journal:  Clin Neuroradiol       Date:  2021-08-11       Impact factor: 3.649

9.  Cardiac Computed Tomography Versus Transesophageal Echocardiography for the Detection of Left Atrial Appendage Thrombus: A Systemic Review and Meta-Analysis.

Authors:  Shandong Yu; Heping Zhang; Hongwei Li
Journal:  J Am Heart Assoc       Date:  2021-11-19       Impact factor: 6.106

10.  Detection of left atrial appendage thrombus by dual-energy computed tomography-derived imaging biomarkers in patients with atrial fibrillation.

Authors:  Wenhuan Li; Mingxi Liu; Fangfang Yu; Weiwei Zhu; Xianbo Yu; Xiaojuan Guo; Qi Yang
Journal:  Front Cardiovasc Med       Date:  2022-07-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.